EMA
Support for Microsoft’s Cloud-Based Dynamics 365 Launches in Kenya & Nigeria
4Sight Dynamics Africa, an indirect cloud solutions provider (CSP) that supports various Microsoft partners in Africa and the Middle East, has announced regional support for the Software as a Service (SaaS) version of Microsoft Dynamics 365 Business Central. From 15 July, small to medium-sized businesses (SMBs) and small, medium and corporate (SMC) Microsoft customers across various territories in the Middle East and Africa (MEA) Multi-Country Cluster (MCC) can access Microsoft Dynamics 365 Business Central from the cloud. “This offering expands on the on-premises availability that 4Sight Dynamics Africa already offers our customers in supported territories and is an important development in our ability to help Microsoft customers in the region realise their strategic cloud transformation ...
Germany starts coronavirus vaccines a day early
A 101-year-old woman in an elderly care home became the first person in Germany to be inoculated against coronavirus on Saturday, a day before the official vaccination campaign was scheduled to get under way in both Germany and the EU. Edith Kwoizalla was one of around 40 residents and 10 staff in a care home in the eastern state of Saxony-Anhalt to receive a jab of the Pfizer-BioNTech vaccine, the home’s manager Tobias Krueger told AFP. The Pfizer-BioNTech vaccine became the first to get the go-ahead for use in the West, when Britain gave its approval on December 2. As other nations from the United States to Saudi Arabia to Singapore followed suit, Germany impatiently prodded the EU’s drugs regulator, the European Medicines Agency, to bring forward its decision from December 29. The EMA f...
EU criticises ‘hasty’ UK approval of coronavirus vaccine
The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot. The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic. The decision was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only ten days after it began examining data from large-scale trials. In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving COVID...
